Compare ADC & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADC | BIO |
|---|---|---|
| Founded | 1971 | 1952 |
| Country | United States | United States |
| Employees | 90 | 7450 |
| Industry | Real Estate Investment Trusts | Biotechnology: Laboratory Analytical Instruments |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 7.1B |
| IPO Year | N/A | N/A |
| Metric | ADC | BIO |
|---|---|---|
| Price | $79.98 | $259.59 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 4 |
| Target Price | $83.35 | ★ $358.50 |
| AVG Volume (30 Days) | ★ 1.1M | 253.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 3.97% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $11.94 | $2.51 |
| Revenue Next Year | $8.44 | $3.17 |
| P/E Ratio | $43.33 | ★ $9.72 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $68.98 | $211.43 |
| 52 Week High | $82.08 | $343.12 |
| Indicator | ADC | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 58.23 | 33.79 |
| Support Level | $70.94 | $251.00 |
| Resistance Level | $82.08 | $264.68 |
| Average True Range (ATR) | 1.28 | 7.95 |
| MACD | -0.37 | -0.51 |
| Stochastic Oscillator | 44.22 | 2.34 |
Agree Realty Corporation operates as a fully integrated real estate investment trust mainly focused on the ownership, acquisition, development and management of retail properties net leased to industry-tenants. The Company is mainly in the business of acquiring, developing and managing retail real estate. Some of its properties in the portfolio include Walmart, 7-Eleven, Wawa, Gerber Collision and others.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.